SMITH & NEPHEW (NPW1 BE) stock market data APIs
€15.915
-0.08(-0.5%)
as of September 17, 2025
Try our APIs with
free plan!
SMITH & NEPHEW Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for NPW1.BE.
Prev. Close
15.915
Open
15.8348
High
16.0256
Low
15.8348
52 wk Range
10.915-16.77
Market Cap
12 680 M
Dividends (Yield)
0.007
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get SMITH & NEPHEW data using free add-ons & libraries
Get SMITH & NEPHEW Fundamental Data
SMITH & NEPHEW Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
SMITH & NEPHEW News
New
Smith & Nephew plc's (LON:SN.) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?
Most readers would already be aware that Smith & Nephew's (LON:SN.) stock increased significantly by 29% over the past three months. However, we decided to pay close attention to its weak financials a...
Smith & Nephew (SNN) Upgraded to Buy: What Does It Mean for the Stock?
Investors might want to bet on Smith & Nephew (SNN), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock...
European Equities Traded in the US as ADRs Fall in Friday Trading
European equities traded in the US as American depositary receipts fell late Friday morning with the PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Smith+Nephew unveils major clinical evidence and patient access updates for its REGENETEN™ Bioinductive Implant
Smith & Nephew UK Ltd Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces new evidence and market updates that highlight the clinical performance of its REGENETEN ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
